Methods 56 patients with IR and fat metabolism disorder were randomly given oral dimethyldiguanide (group A) and Gliclazide capsule (group B) for 3 months.
方法将符合IR及脂代谢紊乱诊断的2型糖尿病患者56例随机分别予口服二甲双胍（A组）、格列齐特（B组）治疗3个月。
Methods 56 patients with IR and fat metabolism disorder were randomly given oral dimethyldiguanide (group A) and Gliclazide capsule (group B) for 3 months.
方法将符合IR及脂代谢紊乱诊断的2型糖尿病患者56例随机分别予口服二甲双胍（A组）、格列齐特（B组）治疗3个月。
应用推荐